The Journal of Terminal Oncology considers current, original articles of interest to oncologists, ethicists, hospital and medical directors, and oncologic nurses regarding the science and ethics of treatment, symptom management, cost management, and quality of life in the post-diagnostic treatment of terminal oncology patients.
The editorial staff is pleased to process and reply to any enquiries received, as well as to advise authors in the preparation of manuscripts. Our goal is to provide relevant, high quality information from diverse sources; to write and publish with absolute integrity; and to serve as effectively as possible the medical and ethical professionals responsible for optimizing end-of-life care of patients dying of cancer.
Please supply your article on a 3 1/2 inch IBM-PC/MS-DOS format floppy. The manuscript file should be in either pure ASCII text, MS Word 6.0 or greater, or rich text format (rtf) (please indicate which.) This will save time typing the manuscript and expedite the preparation of your article. Manuscripts and all correspondence regarding them should be addressed to the Managing Editor, Journal of Terminal Oncology, 470 Boston Post Road, Weston, MA 02493. A manuscript should be submitted typed, double-spaced, with the original and two copies. In most cases, the text should be 1,500 to 2,500 words (seven to 12 pages). You may also send the manuscript electronically to our e-mail address: jto@pnpco.com.
The cover page should indicate the article’s title, the full name, highest pertinent academic degrees, institutional affiliations, and current address of each author, contact information for the author handling all correspondence, telephone number, fax number, and, if the manuscript was orally presented at a meeting, the name of the organization, place, and date it was read. The first use of an uncommon abbreviation should be preceded by the full name. Brief definitions of key terms may be appended to the manuscript and can be presented as marginal notes in the article. With the exception of forum articles, book reviews, or letters to the editor, manuscripts should include the following five sections: Abstract, Introduction, Methods, Results, and Discussion. Subheads should be inserted at suitable levels. Style should conform to “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” prepared by the International Committee of Medical Journal Editors and published in Ann Intern Med 1997; 126(1): 36-47. These guidelines are available on the Web at http://www.acponline.org/journals/annals/ 01jan97/unifreqr.htm.
Journal of Terminal Oncology welcomes figures, tables, and photographs to accompany articles. Figures and tables should be titled and numbered consecutively according to the citation in the text. Information presented in figures and tables should be explained in the text. If data were published previously, an appropriate reference should be included. Legends for figures and tables previously published should include a complete reference to the original publication, with the copyright designation. Copies of the publisher’s and author’s permission to use the figure must be provided. Photographs should be numbered as figures and include captions. Tables, photos, and figures must be submitted in the following formats: TIF, JPEG, or EPS.
Articles containing original material are accepted for consideration with the understanding that they are contributed solely to Journal of Terminal Oncology. Authors should secure all necessary clearances and approvals prior to submission. Journal of Terminal Oncology is a refereed journal. All manuscripts are generally subject to editorial review by two members of the editorial advisory board who are noted experts in the appropriate subject area. Journal of Terminal Oncology reserves the right to make editorial revisions prior to publication. All manuscripts are acknowledged immediately, and every effort will be made to advise contributors of the status of their submissions within 60 days.
Indexing services are pending. Authors are asked to provide a one-paragraph (125 words) abstract summarizing the main points of the article, including a list of keywords.
References should be cited in the text in numerically consecutive order, according to the form:
1. Reisberg B, Ferris S, DeLeon M, Crook R: The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry. 1982; 139: 1136-1139. [for journal articles].
2. Bayles K, Kazniak A: Communication and Cognition in Normal Aging and Dementia. Boston: Little, Brown, and Co., 1987. [for books].
It is necessary for Journal of Terminal Oncology to receive manuscripts as far ahead of deadline dates as possible. Time is needed for the manuscripts to be reviewed, returned to the editor, edited, composed, and printed. All manuscripts should be sent as soon as they are available. We will inform the author when the article will be published. Journal of Terminal Oncology expects authors to disclose any commercial associations that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work should be acknowledged on the title page.
Web Author: Deborah Rines
Last Updated: 10/08/2002
Copyright
©2002 by Prime National Publishing Corporation - ALL RIGHTS
RESERVED